Loading video...

Video Failed to Load

There was a problem loading this video. This could be due to a temporary network issue or the video might be unavailable.

Researchers have identified changes in lymph nodes that could help doctors predict whether breast cancer is likely to spread. Dr Simon Vincent from Breast Cancer Now explains how the findings could impact treatment ⬇️ 📺 Sky 501

Sky News

8,947,512 subscribers

29,280 views • 2 months ago •via X (Twitter)

Health & Wellness News & Politics Science & Technology

Anya Rossi• Live Now

Private livecam show

0 Comments

No comments available

Comments from the original post will appear here

Related Videos

Dr Susan Michaelis explains what makes lobular breast cancer different to other forms of breast cancer. She told JayneSeckerSky why she is setting out to raise awareness and calling for a "moon shot change" 📺 Sky 501, Virgin 602 and YouTube

Dr Susan Michaelis explains what makes lobular breast cancer different to other forms of breast cancer. She told JayneSeckerSky why she is setting out to raise awareness and calling for a "moon shot change" 📺 Sky 501, Virgin 602 and YouTube

Sky News

52,005 views • 3 years ago

Breast screening can detect cancer before you can feel it. Or more likely, put your mind at rest. So when you're invited, save the date. It could save your life. Breast cancer patient and surgeon Dr Dr Liz O'Riordan explains the process from St George's, Epsom and St Helier

Breast screening can detect cancer before you can feel it. Or more likely, put your mind at rest. So when you're invited, save the date. It could save your life. Breast cancer patient and surgeon Dr Dr Liz O'Riordan explains the process from St George's, Epsom and St Helier

Department of Health and Social Care

57,410 views • 1 year ago

The truth about breast-feeding and breast cancer Is it true that 1 in 20 breast cancers could be prevented by breast feeding? This was a statement lifted from the Lancet Breast Cancer Commission Report published yesterday - but it’s a global estimate that assumes EVERY woman in EVERY country has an average of 6 children and breastfeeds them for 1-2 years. The facts - breastfeeding one child for 12 months reduces your lifetime risk of breast cancer by 4% That’s a drop from 17% to 16.4% - so the actual impact is small. The Report wants to increase breast-feeding education and support globally as en masse this will reduce the numbers of breast cancer - but you don’t need to feel guilty if you didn’t breastfeed for that long or didn’t have children If you want to find out your own individual risk of breast cancer, check out the iPrevent tool - Thanks to Wanda (Wanyuan) Cui The Lancet Breast Cancer Now

The truth about breast-feeding and breast cancer Is it true that 1 in 20 breast cancers could be prevented by breast feeding? This was a statement lifted from the Lancet Breast Cancer Commission Report published yesterday - but it’s a global estimate that assumes EVERY woman in EVERY country has an average of 6 children and breastfeeds them for 1-2 years. The facts - breastfeeding one child for 12 months reduces your lifetime risk of breast cancer by 4% That’s a drop from 17% to 16.4% - so the actual impact is small. The Report wants to increase breast-feeding education and support globally as en masse this will reduce the numbers of breast cancer - but you don’t need to feel guilty if you didn’t breastfeed for that long or didn’t have children If you want to find out your own individual risk of breast cancer, check out the iPrevent tool - Thanks to Wanda (Wanyuan) Cui The Lancet Breast Cancer Now

Dr Liz O'Riordan

45,182 views • 2 years ago

Professor Peter Johnson, National Clinical Director for Cancer, explains how the changes to bowel cancer screening could help find more bowel cancers early each year ⬇️ 🎥: BBC Breakfast

Professor Peter Johnson, National Clinical Director for Cancer, explains how the changes to bowel cancer screening could help find more bowel cancers early each year ⬇️ 🎥: BBC Breakfast

NHS England

15,437 views • 6 months ago

'It's still not really that real' Nicola Roberts emotionally remembers her bandmate Sarah Harding. Breast cancer is the biggest killer of women in their 30s. Sarah's dying wish is now reality as a new project to predict the risk of younger women getting breast cancer has begun

'It's still not really that real' Nicola Roberts emotionally remembers her bandmate Sarah Harding. Breast cancer is the biggest killer of women in their 30s. Sarah's dying wish is now reality as a new project to predict the risk of younger women getting breast cancer has begun

Good Morning Britain

110,844 views • 2 years ago

Lobular Cancer is the 2nd most common type of breast cancer, but currently has no specific treatment. After meeting my constituent Katie over the summer and learning more about this type of cancer, I have been working with Dr Susan Michaelis at the Lobular Moonshot Project to campaign for funding to create a dedicated research stream for Lobular Cancer. Today, during PMQs, I asked the Prime Minister if he would meet me and Susan to discuss how the Government can help us save more lives from breast cancer.

Lobular Cancer is the 2nd most common type of breast cancer, but currently has no specific treatment. After meeting my constituent Katie over the summer and learning more about this type of cancer, I have been working with Dr Susan Michaelis at the Lobular Moonshot Project to campaign for funding to create a dedicated research stream for Lobular Cancer. Today, during PMQs, I asked the Prime Minister if he would meet me and Susan to discuss how the Government can help us save more lives from breast cancer.

Dehenna Davison

17,499 views • 2 years ago

Injecting lidocaine directly into breast cancer tumors resulted in a remarkable 29% reduction in mortality, according to a large randomized control trial involving nearly 1,600 patients! Researchers estimate that this simple, accessible approach could save over 100,000 lives worldwide if widely adopted. As we observe Breast Cancer Awareness Month this October, it’s important to spotlight promising discoveries like this. What's even more exciting is that because similar receptors are present in other cancers, lidocaine could potentially be effective for more than just breast cancer. This is exactly why Every Cure exists—to match affordable, old drugs like lidocaine with devastating diseases like cancer, ensuring that every patient can benefit from lifesaving treatments.

Injecting lidocaine directly into breast cancer tumors resulted in a remarkable 29% reduction in mortality, according to a large randomized control trial involving nearly 1,600 patients! Researchers estimate that this simple, accessible approach could save over 100,000 lives worldwide if widely adopted. As we observe Breast Cancer Awareness Month this October, it’s important to spotlight promising discoveries like this. What's even more exciting is that because similar receptors are present in other cancers, lidocaine could potentially be effective for more than just breast cancer. This is exactly why Every Cure exists—to match affordable, old drugs like lidocaine with devastating diseases like cancer, ensuring that every patient can benefit from lifesaving treatments.

David Fajgenbaum, MD

10,520 views • 1 year ago

For most women, the benefits of taking body identical HRT far outweigh any risks. Yet many are reluctant to take it and many doctors are also reluctant to prescribe it. This is usually due to a false belief that HRT is too risky and causes breast cancer. I am sharing with you this paper that has recently been published looking at oestrogen-only HRT and breast cancer incidence. The paper is a meta-analysis, which is a type of statistical analysis where researchers review, combine, and analyse multiple studies together. In this paper, researchers have looked at randomised studies involving oestrogen and breast cancer incidence and put them together to see what the results show. The conclusion is clear: women who take oestrogen-only HRT have a LOWER future risk of developing breast cancer. We’ve known for several years that women who take oestrogen have a lower future incidence of breast cancer as well as other cancers and other conditions. This paper is very reassuring, and it’s worth remembering that any risk of breast cancer has been shown using oestrogen with a combination of a synthetic progestogen, not the body-identical type progesterone healthcare professionals usually prescribe.

For most women, the benefits of taking body identical HRT far outweigh any risks. Yet many are reluctant to take it and many doctors are also reluctant to prescribe it. This is usually due to a false belief that HRT is too risky and causes breast cancer. I am sharing with you this paper that has recently been published looking at oestrogen-only HRT and breast cancer incidence. The paper is a meta-analysis, which is a type of statistical analysis where researchers review, combine, and analyse multiple studies together. In this paper, researchers have looked at randomised studies involving oestrogen and breast cancer incidence and put them together to see what the results show. The conclusion is clear: women who take oestrogen-only HRT have a LOWER future risk of developing breast cancer. We’ve known for several years that women who take oestrogen have a lower future incidence of breast cancer as well as other cancers and other conditions. This paper is very reassuring, and it’s worth remembering that any risk of breast cancer has been shown using oestrogen with a combination of a synthetic progestogen, not the body-identical type progesterone healthcare professionals usually prescribe.

Dr Louise Newson

23,788 views • 2 years ago

In an interview, Dr. Kathleen Ruddy, a distinguished breast cancer surgeon, author, and inventor, shared groundbreaking insights on repurposed drugs for cancer treatment. She discussed how medications like ivermectin, mebendazole, sildenafil, metformin, aspirin, doxycycline, and vitamin C show promise in targeting cancer stem cells, the drivers of tumor regrowth. “Cancer stem cells are the real bad boys,” Dr. Ruddy stated, explaining that chemotherapy and radiation often fail to eliminate them, leading to cancer recurrence. Preclinical studies show combinations like doxycycline and vitamin C can eradicate over 90% of cancer stem cells, with doxycycline, azithromycin, and vitamin C proving equally effective. These affordable, FDA-approved drugs could halt tumors without harming patients. Dr. Ruddy praised Dr. Paul Marik’s Cancer Care monograph as a must-read for its analysis of repurposed drugs. Her mission is to cure cancer, not manage it as a chronic disease. “Patients want to live without cancer,” she emphasized. Through her work, she’s studying these therapies’ impact on cancers like breast, prostate, and lung. “Kill the cancer, or the cancer will kill you,” Dr. Ruddy urged. Could repurposed drugs transform cancer care?

In an interview, Dr. Kathleen Ruddy, a distinguished breast cancer surgeon, author, and inventor, shared groundbreaking insights on repurposed drugs for cancer treatment. She discussed how medications like ivermectin, mebendazole, sildenafil, metformin, aspirin, doxycycline, and vitamin C show promise in targeting cancer stem cells, the drivers of tumor regrowth. “Cancer stem cells are the real bad boys,” Dr. Ruddy stated, explaining that chemotherapy and radiation often fail to eliminate them, leading to cancer recurrence. Preclinical studies show combinations like doxycycline and vitamin C can eradicate over 90% of cancer stem cells, with doxycycline, azithromycin, and vitamin C proving equally effective. These affordable, FDA-approved drugs could halt tumors without harming patients. Dr. Ruddy praised Dr. Paul Marik’s Cancer Care monograph as a must-read for its analysis of repurposed drugs. Her mission is to cure cancer, not manage it as a chronic disease. “Patients want to live without cancer,” she emphasized. Through her work, she’s studying these therapies’ impact on cancers like breast, prostate, and lung. “Kill the cancer, or the cancer will kill you,” Dr. Ruddy urged. Could repurposed drugs transform cancer care?

Camus

117,774 views • 1 year ago

🚨 A HARVARD TRAINED MD JUST EXPLAINED WHY IVERMECTIN IS BEING STUDIED IN CANCER RESEARCH AGAIN And the internet is paying VERY close attention. Dr. Shintani says researchers have explored how Ivermectin may interact with cancer cells in laboratory and preclinical studies involving: • Breast cancer • Prostate cancer • Colon cancer • Lung cancer • Leukemia • Liver cancer • Stomach cancer Why scientists are interested: ✅ Studies suggest Ivermectin may trigger apoptosis, also known as programmed cancer cell death ✅ Researchers are investigating how it may affect tumor growth pathways and cancer stem-like cells ✅ Some preclinical studies are exploring Ivermectin alongside chemotherapy in laboratory models And THAT is why repurposed medicine conversations have exploded across podcasts, TikTok, X, and cancer forums worldwide. Not because the science is settled. Because people are shocked that a low-cost anti-parasitic drug is even being discussed in cancer research at all. But whether critics like it or not… The public conversation around repurposed drugs is getting impossible to ignore.

🚨 A HARVARD TRAINED MD JUST EXPLAINED WHY IVERMECTIN IS BEING STUDIED IN CANCER RESEARCH AGAIN And the internet is paying VERY close attention. Dr. Shintani says researchers have explored how Ivermectin may interact with cancer cells in laboratory and preclinical studies involving: • Breast cancer • Prostate cancer • Colon cancer • Lung cancer • Leukemia • Liver cancer • Stomach cancer Why scientists are interested: ✅ Studies suggest Ivermectin may trigger apoptosis, also known as programmed cancer cell death ✅ Researchers are investigating how it may affect tumor growth pathways and cancer stem-like cells ✅ Some preclinical studies are exploring Ivermectin alongside chemotherapy in laboratory models And THAT is why repurposed medicine conversations have exploded across podcasts, TikTok, X, and cancer forums worldwide. Not because the science is settled. Because people are shocked that a low-cost anti-parasitic drug is even being discussed in cancer research at all. But whether critics like it or not… The public conversation around repurposed drugs is getting impossible to ignore.

Joe Tippens

10,621 views • 2 months ago

UK scientists are to carry out studies on a new "breakthrough" blood test which could be used to detect certain types of brain cancer. CEO of the Brain Tumour Charity Dr Michele Afif talks about the impact this would have. More: 📺 Sky 501, Virgin 602

UK scientists are to carry out studies on a new "breakthrough" blood test which could be used to detect certain types of brain cancer. CEO of the Brain Tumour Charity Dr Michele Afif talks about the impact this would have. More: 📺 Sky 501, Virgin 602

Sky News

59,168 views • 2 years ago

A major research project, in memory of singer Sarah Harding, will look for early signs of breast cancer in young women. Researchers hope the findings will enable all women to have a risk assessment for it at 30. Kimberley Walsh said how it would have meant the world to Sarah.

A major research project, in memory of singer Sarah Harding, will look for early signs of breast cancer in young women. Researchers hope the findings will enable all women to have a risk assessment for it at 30. Kimberley Walsh said how it would have meant the world to Sarah.

BBC Morning Live

108,898 views • 3 years ago

German oncologists have revealed that parasites may play a key role in the development of cancer and now research is showing that Ivermectin, a trusted anti-parasitic with decades of safe use, could also have powerful anticancer effects. This Drug could change cancer treatment.

German oncologists have revealed that parasites may play a key role in the development of cancer and now research is showing that Ivermectin, a trusted anti-parasitic with decades of safe use, could also have powerful anticancer effects. This Drug could change cancer treatment.

Amelia Brown

2,636,398 views • 1 year ago